nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—SLCO1A2—Chlorambucil—testicular cancer	0.155	0.183	CbGbCtD
Nelfinavir—ABCG2—Dactinomycin—testicular cancer	0.0557	0.066	CbGbCtD
Nelfinavir—CYP3A7—Ifosfamide—testicular cancer	0.0486	0.0576	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0486	0.0576	CbGbCtD
Nelfinavir—CYP2B6—Ifosfamide—testicular cancer	0.0462	0.0548	CbGbCtD
Nelfinavir—ABCG2—Carboplatin—testicular cancer	0.0374	0.0444	CbGbCtD
Nelfinavir—CYP3A5—Ifosfamide—testicular cancer	0.0364	0.0432	CbGbCtD
Nelfinavir—ABCG2—Cisplatin—testicular cancer	0.032	0.0379	CbGbCtD
Nelfinavir—ABCG2—Etoposide—testicular cancer	0.0314	0.0372	CbGbCtD
Nelfinavir—CYP2C19—Ifosfamide—testicular cancer	0.0294	0.0348	CbGbCtD
Nelfinavir—SLCO1A2—Methotrexate—testicular cancer	0.0277	0.0328	CbGbCtD
Nelfinavir—SLCO1B1—Methotrexate—testicular cancer	0.0261	0.031	CbGbCtD
Nelfinavir—CYP2C9—Ifosfamide—testicular cancer	0.0244	0.029	CbGbCtD
Nelfinavir—CYP2B6—Cisplatin—testicular cancer	0.0225	0.0267	CbGbCtD
Nelfinavir—ABCG2—Doxorubicin—testicular cancer	0.0214	0.0254	CbGbCtD
Nelfinavir—ABCG2—Methotrexate—testicular cancer	0.0208	0.0246	CbGbCtD
Nelfinavir—ABCB1—Dactinomycin—testicular cancer	0.0201	0.0238	CbGbCtD
Nelfinavir—CYP3A5—Etoposide—testicular cancer	0.0174	0.0206	CbGbCtD
Nelfinavir—CYP2B6—Doxorubicin—testicular cancer	0.0151	0.0179	CbGbCtD
Nelfinavir—CYP3A4—Ifosfamide—testicular cancer	0.0142	0.0168	CbGbCtD
Nelfinavir—CYP1A2—Etoposide—testicular cancer	0.013	0.0154	CbGbCtD
Nelfinavir—ABCB1—Vinblastine—testicular cancer	0.0126	0.0149	CbGbCtD
Nelfinavir—CYP2C9—Cisplatin—testicular cancer	0.0119	0.0141	CbGbCtD
Nelfinavir—CYP2D6—Vinblastine—testicular cancer	0.0119	0.014	CbGbCtD
Nelfinavir—ABCB1—Cisplatin—testicular cancer	0.0115	0.0137	CbGbCtD
Nelfinavir—ABCB1—Etoposide—testicular cancer	0.0113	0.0134	CbGbCtD
Nelfinavir—ABCB1—Doxorubicin—testicular cancer	0.00773	0.00916	CbGbCtD
Nelfinavir—CYP3A4—Vinblastine—testicular cancer	0.00754	0.00893	CbGbCtD
Nelfinavir—ABCB1—Methotrexate—testicular cancer	0.00749	0.00887	CbGbCtD
Nelfinavir—CYP2D6—Doxorubicin—testicular cancer	0.00728	0.00863	CbGbCtD
Nelfinavir—CYP3A4—Etoposide—testicular cancer	0.00679	0.00805	CbGbCtD
Nelfinavir—CYP3A4—Doxorubicin—testicular cancer	0.00463	0.00549	CbGbCtD
Nelfinavir—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000234	0.0015	CcSEcCtD
Nelfinavir—Abdominal distension—Epirubicin—testicular cancer	0.000234	0.0015	CcSEcCtD
Nelfinavir—Asthenia—Dactinomycin—testicular cancer	0.000234	0.0015	CcSEcCtD
Nelfinavir—Neutropenia—Methotrexate—testicular cancer	0.000232	0.00149	CcSEcCtD
Nelfinavir—Dehydration—Doxorubicin—testicular cancer	0.000231	0.00148	CcSEcCtD
Nelfinavir—Paraesthesia—Cisplatin—testicular cancer	0.000231	0.00148	CcSEcCtD
Nelfinavir—Thrombocytopenia—Etoposide—testicular cancer	0.000231	0.00148	CcSEcCtD
Nelfinavir—Liver function test abnormal—Doxorubicin—testicular cancer	0.00023	0.00147	CcSEcCtD
Nelfinavir—Dyspnoea—Cisplatin—testicular cancer	0.000229	0.00147	CcSEcCtD
Nelfinavir—Skin disorder—Etoposide—testicular cancer	0.000229	0.00147	CcSEcCtD
Nelfinavir—Hyperhidrosis—Etoposide—testicular cancer	0.000228	0.00146	CcSEcCtD
Nelfinavir—Pancreatitis—Epirubicin—testicular cancer	0.000228	0.00146	CcSEcCtD
Nelfinavir—Abdominal pain upper—Doxorubicin—testicular cancer	0.000227	0.00145	CcSEcCtD
Nelfinavir—Anorexia—Etoposide—testicular cancer	0.000225	0.00144	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000224	0.00143	CcSEcCtD
Nelfinavir—Decreased appetite—Cisplatin—testicular cancer	0.000224	0.00143	CcSEcCtD
Nelfinavir—Diarrhoea—Dactinomycin—testicular cancer	0.000223	0.00143	CcSEcCtD
Nelfinavir—Pneumonia—Methotrexate—testicular cancer	0.000223	0.00142	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000222	0.00142	CcSEcCtD
Nelfinavir—Vomiting—Bleomycin—testicular cancer	0.000222	0.00142	CcSEcCtD
Nelfinavir—Rash—Bleomycin—testicular cancer	0.00022	0.00141	CcSEcCtD
Nelfinavir—Pain—Cisplatin—testicular cancer	0.00022	0.00141	CcSEcCtD
Nelfinavir—Dermatitis—Bleomycin—testicular cancer	0.00022	0.00141	CcSEcCtD
Nelfinavir—Hypersensitivity—Ifosfamide—testicular cancer	0.00022	0.00141	CcSEcCtD
Nelfinavir—Muscular weakness—Doxorubicin—testicular cancer	0.000219	0.0014	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000219	0.0014	CcSEcCtD
Nelfinavir—Neutropenia—Epirubicin—testicular cancer	0.000217	0.00139	CcSEcCtD
Nelfinavir—Abdominal distension—Doxorubicin—testicular cancer	0.000216	0.00139	CcSEcCtD
Nelfinavir—Stomatitis—Methotrexate—testicular cancer	0.000216	0.00138	CcSEcCtD
Nelfinavir—Asthenia—Ifosfamide—testicular cancer	0.000214	0.00137	CcSEcCtD
Nelfinavir—Sweating—Methotrexate—testicular cancer	0.000212	0.00136	CcSEcCtD
Nelfinavir—Feeling abnormal—Cisplatin—testicular cancer	0.000212	0.00136	CcSEcCtD
Nelfinavir—Paraesthesia—Etoposide—testicular cancer	0.000212	0.00135	CcSEcCtD
Nelfinavir—Pruritus—Ifosfamide—testicular cancer	0.000211	0.00135	CcSEcCtD
Nelfinavir—Pancreatitis—Doxorubicin—testicular cancer	0.000211	0.00135	CcSEcCtD
Nelfinavir—Dyspnoea—Etoposide—testicular cancer	0.00021	0.00134	CcSEcCtD
Nelfinavir—Hyperglycaemia—Epirubicin—testicular cancer	0.00021	0.00134	CcSEcCtD
Nelfinavir—Somnolence—Etoposide—testicular cancer	0.00021	0.00134	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Methotrexate—testicular cancer	0.000209	0.00134	CcSEcCtD
Nelfinavir—Epistaxis—Methotrexate—testicular cancer	0.000209	0.00134	CcSEcCtD
Nelfinavir—Pneumonia—Epirubicin—testicular cancer	0.000208	0.00133	CcSEcCtD
Nelfinavir—Nausea—Bleomycin—testicular cancer	0.000207	0.00133	CcSEcCtD
Nelfinavir—Vomiting—Dactinomycin—testicular cancer	0.000207	0.00133	CcSEcCtD
Nelfinavir—Rash—Dactinomycin—testicular cancer	0.000205	0.00131	CcSEcCtD
Nelfinavir—Decreased appetite—Etoposide—testicular cancer	0.000205	0.00131	CcSEcCtD
Nelfinavir—Diarrhoea—Ifosfamide—testicular cancer	0.000204	0.00131	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Etoposide—testicular cancer	0.000203	0.0013	CcSEcCtD
Nelfinavir—Body temperature increased—Cisplatin—testicular cancer	0.000203	0.0013	CcSEcCtD
Nelfinavir—Stomatitis—Epirubicin—testicular cancer	0.000202	0.00129	CcSEcCtD
Nelfinavir—Jaundice—Epirubicin—testicular cancer	0.000202	0.00129	CcSEcCtD
Nelfinavir—Pain—Etoposide—testicular cancer	0.000202	0.00129	CcSEcCtD
Nelfinavir—Neutropenia—Doxorubicin—testicular cancer	0.000201	0.00129	CcSEcCtD
Nelfinavir—Haemoglobin—Methotrexate—testicular cancer	0.0002	0.00128	CcSEcCtD
Nelfinavir—Hepatitis—Methotrexate—testicular cancer	0.000199	0.00127	CcSEcCtD
Nelfinavir—Haemorrhage—Methotrexate—testicular cancer	0.000199	0.00127	CcSEcCtD
Nelfinavir—Sweating—Epirubicin—testicular cancer	0.000199	0.00127	CcSEcCtD
Nelfinavir—Dizziness—Ifosfamide—testicular cancer	0.000197	0.00126	CcSEcCtD
Nelfinavir—Pharyngitis—Methotrexate—testicular cancer	0.000197	0.00126	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Epirubicin—testicular cancer	0.000196	0.00125	CcSEcCtD
Nelfinavir—Epistaxis—Epirubicin—testicular cancer	0.000195	0.00125	CcSEcCtD
Nelfinavir—Sinusitis—Epirubicin—testicular cancer	0.000194	0.00124	CcSEcCtD
Nelfinavir—Feeling abnormal—Etoposide—testicular cancer	0.000194	0.00124	CcSEcCtD
Nelfinavir—Hyperglycaemia—Doxorubicin—testicular cancer	0.000194	0.00124	CcSEcCtD
Nelfinavir—Nausea—Dactinomycin—testicular cancer	0.000193	0.00124	CcSEcCtD
Nelfinavir—Pneumonia—Doxorubicin—testicular cancer	0.000193	0.00123	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Etoposide—testicular cancer	0.000193	0.00123	CcSEcCtD
Nelfinavir—Vomiting—Ifosfamide—testicular cancer	0.00019	0.00121	CcSEcCtD
Nelfinavir—Hypersensitivity—Cisplatin—testicular cancer	0.00019	0.00121	CcSEcCtD
Nelfinavir—Rash—Ifosfamide—testicular cancer	0.000188	0.0012	CcSEcCtD
Nelfinavir—Dermatitis—Ifosfamide—testicular cancer	0.000188	0.0012	CcSEcCtD
Nelfinavir—Erythema multiforme—Methotrexate—testicular cancer	0.000188	0.0012	CcSEcCtD
Nelfinavir—Urticaria—Etoposide—testicular cancer	0.000187	0.0012	CcSEcCtD
Nelfinavir—Haemoglobin—Epirubicin—testicular cancer	0.000187	0.0012	CcSEcCtD
Nelfinavir—Stomatitis—Doxorubicin—testicular cancer	0.000187	0.0012	CcSEcCtD
Nelfinavir—Jaundice—Doxorubicin—testicular cancer	0.000187	0.0012	CcSEcCtD
Nelfinavir—Rhinitis—Epirubicin—testicular cancer	0.000186	0.00119	CcSEcCtD
Nelfinavir—Abdominal pain—Etoposide—testicular cancer	0.000186	0.00119	CcSEcCtD
Nelfinavir—Body temperature increased—Etoposide—testicular cancer	0.000186	0.00119	CcSEcCtD
Nelfinavir—Haemorrhage—Epirubicin—testicular cancer	0.000186	0.00119	CcSEcCtD
Nelfinavir—Hepatitis—Epirubicin—testicular cancer	0.000186	0.00119	CcSEcCtD
Nelfinavir—Eye disorder—Methotrexate—testicular cancer	0.000186	0.00119	CcSEcCtD
Nelfinavir—Asthenia—Cisplatin—testicular cancer	0.000185	0.00118	CcSEcCtD
Nelfinavir—Pharyngitis—Epirubicin—testicular cancer	0.000185	0.00118	CcSEcCtD
Nelfinavir—Sweating—Doxorubicin—testicular cancer	0.000184	0.00118	CcSEcCtD
Nelfinavir—Connective tissue disorder—Epirubicin—testicular cancer	0.000183	0.00117	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000181	0.00116	CcSEcCtD
Nelfinavir—Epistaxis—Doxorubicin—testicular cancer	0.000181	0.00116	CcSEcCtD
Nelfinavir—Angiopathy—Methotrexate—testicular cancer	0.00018	0.00115	CcSEcCtD
Nelfinavir—Sinusitis—Doxorubicin—testicular cancer	0.00018	0.00115	CcSEcCtD
Nelfinavir—Immune system disorder—Methotrexate—testicular cancer	0.000179	0.00115	CcSEcCtD
Nelfinavir—Nausea—Ifosfamide—testicular cancer	0.000177	0.00113	CcSEcCtD
Nelfinavir—Diarrhoea—Cisplatin—testicular cancer	0.000176	0.00113	CcSEcCtD
Nelfinavir—Erythema multiforme—Epirubicin—testicular cancer	0.000176	0.00113	CcSEcCtD
Nelfinavir—Eye disorder—Epirubicin—testicular cancer	0.000174	0.00111	CcSEcCtD
Nelfinavir—Hypersensitivity—Etoposide—testicular cancer	0.000174	0.00111	CcSEcCtD
Nelfinavir—Erythema—Methotrexate—testicular cancer	0.000173	0.00111	CcSEcCtD
Nelfinavir—Malnutrition—Methotrexate—testicular cancer	0.000173	0.00111	CcSEcCtD
Nelfinavir—Haemoglobin—Doxorubicin—testicular cancer	0.000173	0.00111	CcSEcCtD
Nelfinavir—Rhinitis—Doxorubicin—testicular cancer	0.000173	0.0011	CcSEcCtD
Nelfinavir—Haemorrhage—Doxorubicin—testicular cancer	0.000172	0.0011	CcSEcCtD
Nelfinavir—Hepatitis—Doxorubicin—testicular cancer	0.000172	0.0011	CcSEcCtD
Nelfinavir—Pharyngitis—Doxorubicin—testicular cancer	0.000171	0.00109	CcSEcCtD
Nelfinavir—Asthenia—Etoposide—testicular cancer	0.000169	0.00108	CcSEcCtD
Nelfinavir—Connective tissue disorder—Doxorubicin—testicular cancer	0.000169	0.00108	CcSEcCtD
Nelfinavir—Angiopathy—Epirubicin—testicular cancer	0.000169	0.00108	CcSEcCtD
Nelfinavir—Immune system disorder—Epirubicin—testicular cancer	0.000168	0.00108	CcSEcCtD
Nelfinavir—Back pain—Methotrexate—testicular cancer	0.000167	0.00107	CcSEcCtD
Nelfinavir—Pruritus—Etoposide—testicular cancer	0.000167	0.00107	CcSEcCtD
Nelfinavir—Vomiting—Cisplatin—testicular cancer	0.000164	0.00105	CcSEcCtD
Nelfinavir—Erythema multiforme—Doxorubicin—testicular cancer	0.000163	0.00104	CcSEcCtD
Nelfinavir—Rash—Cisplatin—testicular cancer	0.000162	0.00104	CcSEcCtD
Nelfinavir—Dermatitis—Cisplatin—testicular cancer	0.000162	0.00104	CcSEcCtD
Nelfinavir—Malnutrition—Epirubicin—testicular cancer	0.000162	0.00104	CcSEcCtD
Nelfinavir—Erythema—Epirubicin—testicular cancer	0.000162	0.00104	CcSEcCtD
Nelfinavir—Diarrhoea—Etoposide—testicular cancer	0.000161	0.00103	CcSEcCtD
Nelfinavir—Eye disorder—Doxorubicin—testicular cancer	0.000161	0.00103	CcSEcCtD
Nelfinavir—Ill-defined disorder—Methotrexate—testicular cancer	0.00016	0.00103	CcSEcCtD
Nelfinavir—Anaemia—Methotrexate—testicular cancer	0.00016	0.00102	CcSEcCtD
Nelfinavir—Flatulence—Epirubicin—testicular cancer	0.00016	0.00102	CcSEcCtD
Nelfinavir—Back pain—Epirubicin—testicular cancer	0.000157	0.001	CcSEcCtD
Nelfinavir—Angiopathy—Doxorubicin—testicular cancer	0.000156	0.000999	CcSEcCtD
Nelfinavir—Malaise—Methotrexate—testicular cancer	0.000156	0.000998	CcSEcCtD
Nelfinavir—Dizziness—Etoposide—testicular cancer	0.000156	0.000998	CcSEcCtD
Nelfinavir—Muscle spasms—Epirubicin—testicular cancer	0.000156	0.000996	CcSEcCtD
Nelfinavir—Immune system disorder—Doxorubicin—testicular cancer	0.000155	0.000995	CcSEcCtD
Nelfinavir—Leukopenia—Methotrexate—testicular cancer	0.000155	0.000991	CcSEcCtD
Nelfinavir—Nausea—Cisplatin—testicular cancer	0.000153	0.000978	CcSEcCtD
Nelfinavir—Ill-defined disorder—Epirubicin—testicular cancer	0.00015	0.000961	CcSEcCtD
Nelfinavir—Convulsion—Methotrexate—testicular cancer	0.00015	0.000959	CcSEcCtD
Nelfinavir—Vomiting—Etoposide—testicular cancer	0.00015	0.000959	CcSEcCtD
Nelfinavir—Malnutrition—Doxorubicin—testicular cancer	0.00015	0.000959	CcSEcCtD
Nelfinavir—Erythema—Doxorubicin—testicular cancer	0.00015	0.000959	CcSEcCtD
Nelfinavir—Anaemia—Epirubicin—testicular cancer	0.00015	0.000958	CcSEcCtD
Nelfinavir—Agitation—Epirubicin—testicular cancer	0.000149	0.000952	CcSEcCtD
Nelfinavir—Rash—Etoposide—testicular cancer	0.000149	0.000951	CcSEcCtD
Nelfinavir—Dermatitis—Etoposide—testicular cancer	0.000148	0.00095	CcSEcCtD
Nelfinavir—Headache—Etoposide—testicular cancer	0.000148	0.000945	CcSEcCtD
Nelfinavir—Flatulence—Doxorubicin—testicular cancer	0.000148	0.000945	CcSEcCtD
Nelfinavir—Myalgia—Methotrexate—testicular cancer	0.000147	0.000943	CcSEcCtD
Nelfinavir—Arthralgia—Methotrexate—testicular cancer	0.000147	0.000943	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000146	0.000936	CcSEcCtD
Nelfinavir—Malaise—Epirubicin—testicular cancer	0.000146	0.000934	CcSEcCtD
Nelfinavir—Discomfort—Methotrexate—testicular cancer	0.000146	0.000931	CcSEcCtD
Nelfinavir—Leukopenia—Epirubicin—testicular cancer	0.000145	0.000927	CcSEcCtD
Nelfinavir—Back pain—Doxorubicin—testicular cancer	0.000145	0.000927	CcSEcCtD
Nelfinavir—Muscle spasms—Doxorubicin—testicular cancer	0.000144	0.000922	CcSEcCtD
Nelfinavir—Convulsion—Epirubicin—testicular cancer	0.00014	0.000898	CcSEcCtD
Nelfinavir—Nausea—Etoposide—testicular cancer	0.00014	0.000896	CcSEcCtD
Nelfinavir—Ill-defined disorder—Doxorubicin—testicular cancer	0.000139	0.000889	CcSEcCtD
Nelfinavir—Anaemia—Doxorubicin—testicular cancer	0.000138	0.000886	CcSEcCtD
Nelfinavir—Thrombocytopenia—Methotrexate—testicular cancer	0.000138	0.000885	CcSEcCtD
Nelfinavir—Arthralgia—Epirubicin—testicular cancer	0.000138	0.000882	CcSEcCtD
Nelfinavir—Myalgia—Epirubicin—testicular cancer	0.000138	0.000882	CcSEcCtD
Nelfinavir—Agitation—Doxorubicin—testicular cancer	0.000138	0.000881	CcSEcCtD
Nelfinavir—Anxiety—Epirubicin—testicular cancer	0.000137	0.000879	CcSEcCtD
Nelfinavir—Skin disorder—Methotrexate—testicular cancer	0.000137	0.000878	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000137	0.000876	CcSEcCtD
Nelfinavir—Hyperhidrosis—Methotrexate—testicular cancer	0.000136	0.000873	CcSEcCtD
Nelfinavir—Discomfort—Epirubicin—testicular cancer	0.000136	0.000871	CcSEcCtD
Nelfinavir—Malaise—Doxorubicin—testicular cancer	0.000135	0.000865	CcSEcCtD
Nelfinavir—Anorexia—Methotrexate—testicular cancer	0.000135	0.000861	CcSEcCtD
Nelfinavir—Leukopenia—Doxorubicin—testicular cancer	0.000134	0.000858	CcSEcCtD
Nelfinavir—Oedema—Epirubicin—testicular cancer	0.000132	0.000846	CcSEcCtD
Nelfinavir—Convulsion—Doxorubicin—testicular cancer	0.00013	0.000831	CcSEcCtD
Nelfinavir—Thrombocytopenia—Epirubicin—testicular cancer	0.000129	0.000828	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000129	0.000823	CcSEcCtD
Nelfinavir—Skin disorder—Epirubicin—testicular cancer	0.000128	0.000821	CcSEcCtD
Nelfinavir—Hyperhidrosis—Epirubicin—testicular cancer	0.000128	0.000817	CcSEcCtD
Nelfinavir—Insomnia—Methotrexate—testicular cancer	0.000128	0.000817	CcSEcCtD
Nelfinavir—Arthralgia—Doxorubicin—testicular cancer	0.000128	0.000816	CcSEcCtD
Nelfinavir—Myalgia—Doxorubicin—testicular cancer	0.000128	0.000816	CcSEcCtD
Nelfinavir—Anxiety—Doxorubicin—testicular cancer	0.000127	0.000813	CcSEcCtD
Nelfinavir—Paraesthesia—Methotrexate—testicular cancer	0.000127	0.000811	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000127	0.000811	CcSEcCtD
Nelfinavir—Discomfort—Doxorubicin—testicular cancer	0.000126	0.000806	CcSEcCtD
Nelfinavir—Anorexia—Epirubicin—testicular cancer	0.000126	0.000806	CcSEcCtD
Nelfinavir—Dyspnoea—Methotrexate—testicular cancer	0.000126	0.000806	CcSEcCtD
Nelfinavir—Somnolence—Methotrexate—testicular cancer	0.000126	0.000803	CcSEcCtD
Nelfinavir—Dyspepsia—Methotrexate—testicular cancer	0.000124	0.000795	CcSEcCtD
Nelfinavir—Decreased appetite—Methotrexate—testicular cancer	0.000123	0.000785	CcSEcCtD
Nelfinavir—Oedema—Doxorubicin—testicular cancer	0.000122	0.000782	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000122	0.00078	CcSEcCtD
Nelfinavir—Pain—Methotrexate—testicular cancer	0.000121	0.000773	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00012	0.00077	CcSEcCtD
Nelfinavir—Thrombocytopenia—Doxorubicin—testicular cancer	0.00012	0.000766	CcSEcCtD
Nelfinavir—Insomnia—Epirubicin—testicular cancer	0.000119	0.000765	CcSEcCtD
Nelfinavir—Skin disorder—Doxorubicin—testicular cancer	0.000119	0.00076	CcSEcCtD
Nelfinavir—Paraesthesia—Epirubicin—testicular cancer	0.000119	0.000759	CcSEcCtD
Nelfinavir—Hyperhidrosis—Doxorubicin—testicular cancer	0.000118	0.000756	CcSEcCtD
Nelfinavir—Dyspnoea—Epirubicin—testicular cancer	0.000118	0.000754	CcSEcCtD
Nelfinavir—Somnolence—Epirubicin—testicular cancer	0.000117	0.000752	CcSEcCtD
Nelfinavir—Anorexia—Doxorubicin—testicular cancer	0.000117	0.000746	CcSEcCtD
Nelfinavir—Feeling abnormal—Methotrexate—testicular cancer	0.000116	0.000745	CcSEcCtD
Nelfinavir—Dyspepsia—Epirubicin—testicular cancer	0.000116	0.000744	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Methotrexate—testicular cancer	0.000115	0.000739	CcSEcCtD
Nelfinavir—Decreased appetite—Epirubicin—testicular cancer	0.000115	0.000735	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000114	0.00073	CcSEcCtD
Nelfinavir—Pain—Epirubicin—testicular cancer	0.000113	0.000723	CcSEcCtD
Nelfinavir—Urticaria—Methotrexate—testicular cancer	0.000112	0.000718	CcSEcCtD
Nelfinavir—Abdominal pain—Methotrexate—testicular cancer	0.000112	0.000714	CcSEcCtD
Nelfinavir—Body temperature increased—Methotrexate—testicular cancer	0.000112	0.000714	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000111	0.000713	CcSEcCtD
Nelfinavir—Insomnia—Doxorubicin—testicular cancer	0.000111	0.000708	CcSEcCtD
Nelfinavir—Paraesthesia—Doxorubicin—testicular cancer	0.00011	0.000703	CcSEcCtD
Nelfinavir—Dyspnoea—Doxorubicin—testicular cancer	0.000109	0.000698	CcSEcCtD
Nelfinavir—Feeling abnormal—Epirubicin—testicular cancer	0.000109	0.000697	CcSEcCtD
Nelfinavir—Somnolence—Doxorubicin—testicular cancer	0.000109	0.000696	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Epirubicin—testicular cancer	0.000108	0.000691	CcSEcCtD
Nelfinavir—Dyspepsia—Doxorubicin—testicular cancer	0.000108	0.000689	CcSEcCtD
Nelfinavir—Decreased appetite—Doxorubicin—testicular cancer	0.000106	0.00068	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000106	0.000675	CcSEcCtD
Nelfinavir—Urticaria—Epirubicin—testicular cancer	0.000105	0.000672	CcSEcCtD
Nelfinavir—Pain—Doxorubicin—testicular cancer	0.000105	0.000669	CcSEcCtD
Nelfinavir—Body temperature increased—Epirubicin—testicular cancer	0.000104	0.000668	CcSEcCtD
Nelfinavir—Abdominal pain—Epirubicin—testicular cancer	0.000104	0.000668	CcSEcCtD
Nelfinavir—Hypersensitivity—Methotrexate—testicular cancer	0.000104	0.000666	CcSEcCtD
Nelfinavir—Asthenia—Methotrexate—testicular cancer	0.000101	0.000648	CcSEcCtD
Nelfinavir—Feeling abnormal—Doxorubicin—testicular cancer	0.000101	0.000645	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Doxorubicin—testicular cancer	0.0001	0.00064	CcSEcCtD
Nelfinavir—Pruritus—Methotrexate—testicular cancer	9.99e-05	0.000639	CcSEcCtD
Nelfinavir—Hypersensitivity—Epirubicin—testicular cancer	9.73e-05	0.000623	CcSEcCtD
Nelfinavir—Urticaria—Doxorubicin—testicular cancer	9.71e-05	0.000622	CcSEcCtD
Nelfinavir—Body temperature increased—Doxorubicin—testicular cancer	9.66e-05	0.000618	CcSEcCtD
Nelfinavir—Abdominal pain—Doxorubicin—testicular cancer	9.66e-05	0.000618	CcSEcCtD
Nelfinavir—Diarrhoea—Methotrexate—testicular cancer	9.66e-05	0.000618	CcSEcCtD
Nelfinavir—Asthenia—Epirubicin—testicular cancer	9.48e-05	0.000607	CcSEcCtD
Nelfinavir—Pruritus—Epirubicin—testicular cancer	9.35e-05	0.000598	CcSEcCtD
Nelfinavir—Dizziness—Methotrexate—testicular cancer	9.34e-05	0.000597	CcSEcCtD
Nelfinavir—Diarrhoea—Epirubicin—testicular cancer	9.04e-05	0.000579	CcSEcCtD
Nelfinavir—Hypersensitivity—Doxorubicin—testicular cancer	9.01e-05	0.000576	CcSEcCtD
Nelfinavir—Vomiting—Methotrexate—testicular cancer	8.98e-05	0.000574	CcSEcCtD
Nelfinavir—Rash—Methotrexate—testicular cancer	8.9e-05	0.00057	CcSEcCtD
Nelfinavir—Dermatitis—Methotrexate—testicular cancer	8.89e-05	0.000569	CcSEcCtD
Nelfinavir—Headache—Methotrexate—testicular cancer	8.84e-05	0.000566	CcSEcCtD
Nelfinavir—Asthenia—Doxorubicin—testicular cancer	8.77e-05	0.000561	CcSEcCtD
Nelfinavir—Dizziness—Epirubicin—testicular cancer	8.74e-05	0.000559	CcSEcCtD
Nelfinavir—Pruritus—Doxorubicin—testicular cancer	8.65e-05	0.000554	CcSEcCtD
Nelfinavir—Vomiting—Epirubicin—testicular cancer	8.4e-05	0.000538	CcSEcCtD
Nelfinavir—Nausea—Methotrexate—testicular cancer	8.39e-05	0.000537	CcSEcCtD
Nelfinavir—Diarrhoea—Doxorubicin—testicular cancer	8.36e-05	0.000535	CcSEcCtD
Nelfinavir—Rash—Epirubicin—testicular cancer	8.33e-05	0.000533	CcSEcCtD
Nelfinavir—Dermatitis—Epirubicin—testicular cancer	8.32e-05	0.000533	CcSEcCtD
Nelfinavir—Headache—Epirubicin—testicular cancer	8.28e-05	0.00053	CcSEcCtD
Nelfinavir—Dizziness—Doxorubicin—testicular cancer	8.08e-05	0.000517	CcSEcCtD
Nelfinavir—Nausea—Epirubicin—testicular cancer	7.85e-05	0.000502	CcSEcCtD
Nelfinavir—Vomiting—Doxorubicin—testicular cancer	7.77e-05	0.000497	CcSEcCtD
Nelfinavir—Rash—Doxorubicin—testicular cancer	7.71e-05	0.000493	CcSEcCtD
Nelfinavir—Dermatitis—Doxorubicin—testicular cancer	7.7e-05	0.000493	CcSEcCtD
Nelfinavir—Headache—Doxorubicin—testicular cancer	7.66e-05	0.00049	CcSEcCtD
Nelfinavir—Nausea—Doxorubicin—testicular cancer	7.26e-05	0.000465	CcSEcCtD
